BACKGROUND: Genetic studies in adults indicate that genes influencing the personality trait of neuroticism account for substantial genetic variance in anxiety and depression and in somatic health. Here, we examine for the first time the factors underlying the relationship between neuroticism and anxiety/depressive and somatic symptoms during adolescence. METHOD: The Somatic and Psychological Health Report (SPHERE) assessed symptoms of anxiety/depression (PSYCH-14) and somatic distress (SOMA-10) in 2459 adolescent and young adult twins [1168 complete pairs (35.4% monozygotic, 53% female)] aged 12-25 years (mean=15.5 ± 2.9). Differences between boys and girls across adolescence were explored for neuroticism, SPHERE-34, and the subscales PSYCH-14 and SOMA-10. Trivariate analyses partitioned sources of covariance in neuroticism, PSYCH-14 and SOMA-10. RESULTS: Girls scored higher than boys on both neuroticism and SPHERE, with SPHERE scores for girls increasing slightly over time, whereas scores for boys decreased or were unchanged. Neuroticism and SPHERE scores were strongly influenced by genetic factors [heritability (h(2)) = 40-52%]. A common genetic source influenced neuroticism, PSYCH-14 and SOMA-10 (impacting PSYCH-14 more than SOMA-10). A further genetic source, independent of neuroticism, accounted for covariation specific to PSYCH-14 and SOMA-10. Environmental influences were largely specific to each measure. CONCLUSIONS: In adolescence, genetic risk factors indexed by neuroticism contribute substantially to anxiety/depression and, to a lesser extent, perceived somatic health. Additional genetic covariation between anxiety/depressive and somatic symptoms, independent of neuroticism, had greatest influence on somatic distress, where it was equal in influence to the factor shared with neuroticism.
BACKGROUND: Genetic studies in adults indicate that genes influencing the personality trait of neuroticism account for substantial genetic variance in anxiety and depression and in somatic health. Here, we examine for the first time the factors underlying the relationship between neuroticism and anxiety/depressive and somatic symptoms during adolescence. METHOD: The Somatic and Psychological Health Report (SPHERE) assessed symptoms of anxiety/depression (PSYCH-14) and somatic distress (SOMA-10) in 2459 adolescent and young adult twins [1168 complete pairs (35.4% monozygotic, 53% female)] aged 12-25 years (mean=15.5 ± 2.9). Differences between boys and girls across adolescence were explored for neuroticism, SPHERE-34, and the subscales PSYCH-14 and SOMA-10. Trivariate analyses partitioned sources of covariance in neuroticism, PSYCH-14 and SOMA-10. RESULTS:Girls scored higher than boys on both neuroticism and SPHERE, with SPHERE scores for girls increasing slightly over time, whereas scores for boys decreased or were unchanged. Neuroticism and SPHERE scores were strongly influenced by genetic factors [heritability (h(2)) = 40-52%]. A common genetic source influenced neuroticism, PSYCH-14 and SOMA-10 (impacting PSYCH-14 more than SOMA-10). A further genetic source, independent of neuroticism, accounted for covariation specific to PSYCH-14 and SOMA-10. Environmental influences were largely specific to each measure. CONCLUSIONS: In adolescence, genetic risk factors indexed by neuroticism contribute substantially to anxiety/depression and, to a lesser extent, perceived somatic health. Additional genetic covariation between anxiety/depressive and somatic symptoms, independent of neuroticism, had greatest influence on somatic distress, where it was equal in influence to the factor shared with neuroticism.
Authors: Madeline H Meier; Nathan A Gillespie; Narelle K Hansell; Alex W Hewitt; Ian B Hickie; Yi Lu; Stuart MacGregor; Sarah E Medland; Cong Sun; Tien Y Wong; Margaret J Wright; Gu Zhu; Nicholas G Martin; David A Mackey Journal: Psychosom Med Date: 2014 Nov-Dec Impact factor: 4.312
Authors: Jacob J Crouse; Nicholas Ho; Jan Scott; Richard Parker; Shin Ho Park; Baptiste Couvy-Duchesne; Brittany L Mitchell; Enda M Byrne; Daniel F Hermens; Sarah E Medland; Nicholas G Martin; Nathan A Gillespie; Ian B Hickie Journal: Eur Psychiatry Date: 2022-06-13 Impact factor: 7.156
Authors: Nathan A Gillespie; Anjali K Henders; Tracy A Davenport; Daniel F Hermens; Margie J Wright; Nicholas G Martin; Ian B Hickie Journal: Twin Res Hum Genet Date: 2012-11-28 Impact factor: 1.587
Authors: Tomislav D Zbozinek; Raphael D Rose; Kate B Wolitzky-Taylor; Cathy Sherbourne; Greer Sullivan; Murray B Stein; Peter P Roy-Byrne; Michelle G Craske Journal: Depress Anxiety Date: 2012-11-26 Impact factor: 6.505
Authors: Monika A Waszczuk; Nicholas R Eaton; Robert F Krueger; Alexander J Shackman; Irwin D Waldman; David H Zald; Benjamin B Lahey; Christopher J Patrick; Christopher C Conway; Johan Ormel; Steven E Hyman; Eiko I Fried; Miriam K Forbes; Anna R Docherty; Robert R Althoff; Bo Bach; Michael Chmielewski; Colin G DeYoung; Kelsie T Forbush; Michael Hallquist; Christopher J Hopwood; Masha Y Ivanova; Katherine G Jonas; Robert D Latzman; Kristian E Markon; Stephanie N Mullins-Sweatt; Aaron L Pincus; Ulrich Reininghaus; Susan C South; Jennifer L Tackett; David Watson; Aidan G C Wright; Roman Kotov Journal: J Abnorm Psychol Date: 2019-12-05
Authors: Ian B Hickie; Jan Scott; Daniel F Hermens; Elizabeth M Scott; Sharon L Naismith; Adam J Guastella; Nick Glozier; Patrick D McGorry Journal: BMC Med Date: 2013-05-14 Impact factor: 8.775
Authors: S L Naismith; D F Hermens; T K C Ip; S Bolitho; E Scott; N L Rogers; I B Hickie Journal: Transl Psychiatry Date: 2012-05-29 Impact factor: 6.222